查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
CRISPR和Cas基因市場規模,份額和趨勢分析報告：按用戶（CRO,生物技術和製藥）,應用（生物醫學,農業）,產品和服務,地區細分市場預測2022-2030
市場調查報告書
商品編碼
1147491

CRISPR和Cas基因市場規模,份額和趨勢分析報告：按用戶（CRO,生物技術和製藥）,應用（生物醫學,農業）,產品和服務,地區細分市場預測2022-2030

CRISPR And Cas Genes Market Size, Share & Trends Analysis Report By End-use (CROs, Biotech & Pharma Companies), By Application (Biomedical, Agriculture), By Product & Service, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 170 Pages | 商品交期: 2-10個工作天內

價格

CRISPR 和 Cas 基因的市場增長和趨勢

根據 Grand View Research, Inc. 的最新報告，到 2030 年，全球 CRISPR 和 Cas 基因市場規模預計將達到 96 億美元。由於 CRISPR 和 Cas 基因係統在生物醫學研究領域的應用越來越廣泛，預計該市場在預測期內的複合年增長率將達到 17.9%。基因組編輯領域的進步大大增加了 CRISPR-Cas 系統在原核診斷和進化分析評估中的使用。該技術的應用使得基因編輯變得容易且成本低成為可能。基因組編輯極大地推進了生物醫學研究，當前最先進的趨勢為未來治療各種遺傳和非遺傳疾病鋪平了道路。

CRISPR/Cas9 介導的基因和基因組編輯技術的使用促進了更有效的基因打靶方法的開發和實施以及基因編輯鳥類的培育。根據 2021 年 2 月發表在 Frontiers 上的一篇論文，CRISPR/Cas9 已成為家禽業基因編輯的強大而重要的工具。多個領域的潛在應用將進一步推動對該技術的需求。 COVID-19 的爆發已將研究人員的注意力轉移到開發基於該技術的 COVID-19 分子診斷工具上。例如，2021 年 3 月，新加坡南洋理工大學的研究人員創建了一種基於 CRISPR 的 COVID-19 測試，可在 30 分鐘內得出結果。

即使病毒已經變異，這個測試也會發現它。這將進一步鼓勵其他主要參與者利用這項技術，從而推動行業增長。這項技術越來越多地用於醫療和其他應用。隨著越來越多的學術機構和生物技術公司尋求為該技術開發新的商業應用，預計此類基因編輯技術的專利競爭將會加劇。此外，該技術有可能通過使用機器學習技術進一步發展。例如，2022 年 8 月，Synthego 將提供工程細胞庫，這是一項擴大 CRISPR 訪問的尖端服務，提供 CRISPR 編輯的細胞陣列，可直接用於功能篩選實驗。

有望應用於疾病研究。領先企業為基因編輯工作流程的每一步提供工具和解決方案。通過集成多種工具、服務和改進的流程，可以更快、更輕鬆地完成研究實驗。此外，主要參與者已經籌集了大量資金來支持 CRISPR 和 Cas9 基因編輯方法的研發。例如，2021 年 4 月，Vertex Pharmaceuticals 與 CRISPR Therapeutics 合作開發和製造 CTX001，這是一種基於 CRISPR/Cas9 的新型基因編輯療法，可能成為輸血依賴性Beta-地中海貧血和鐮狀細胞病 (SCD) 的治療選擇.宣布它將2020 年 1 月，Mammoth Biosciences 籌集了 4500 萬美元用於開發用於治療和診斷目的的下一代 CRISPR 產品。它還將用於開發公司的 CRISPR 基因驅動診斷產品組合。

CRISPR 和 Cas 基因市場報告要點

在產品和服務方面，由於廣泛的產品組合的可用性以及越來越多的最終用戶採用，該產品領域在 2021 年佔據了行業主導地位。

生物醫藥領域將在 2021 年主導該行業。利用先進的基因組編輯技術進行的廣泛研究和研究數量的顯著增加促進了細分市場的增長

生物技術和製藥公司的最終用途部分將在 2021 年佔據主要收入份額。主要參與者正在採用該技術來創建人類疾病的生物學模型，並進一步加速新治療靶點的識別

由於多家製藥巨頭的存在、研究資金的增加、研究批准的高水平以及對新療法的需求，北美將在 2021 年獲得最高的收入份額。

內容

第 1 章調查方法及範圍

  • 市場細分和範圍
    • 區域範圍
  • 調查方法
  • 資訊採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要資訊
    • 初步調查
  • 資訊或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細資訊
    • 商品流分析（模型 1）
      • 方法 1：商品流方法
  • 調查假設
  • 計算市場份額
  • 次要資訊列表
  • 縮寫列表
  • 目的

第 2 章執行摘要

  • 市場概覽

第 3 章 CRISPR 和 Cas 基因市場變量、趨勢和範圍

  • 市場細分和範圍
  • 市場促進因素分析
    • 對新療法的需求不斷增長
    • 對基因編輯的需求不斷增長
    • 癌症發病率增加
  • 市場抑制因素分析
    • Crispr 技術的脫靶效應
    • 高成本因素、知識產權糾紛、道德困境
  • Crispr 和 Cas 基因市場 Swot 分析，按因素（政治和法律、經濟和技術）
  • 行業分析 - 波特

第 4 章產品和服務的業務分析

  • CRISPR 和 Cas 基因市場：產品和服務的差異分析
    • 按產品分類
      • 試劑盒和□
      • 基於載體的 Cas9
      • 無 DNA Cas9
      • 函式庫
      • 設計工具
      • 抗體
      • 其他
    • 按服務
      • 細胞系工程
      • gRNA 設計
      • 微生物基因編輯
      • DNA合成

第 5 章應用業務分析

  • CRISPR 和 Cas 基因市場：應用差異分析
    • 生物醫學
      • 基因組工程
      • 疾病模型研究
      • 功能基因組學
      • 表觀遺傳學
      • 其他
    • 農業

第 6 章最終用途業務分析

  • CRISPR 和 Cas 基因市場：最終用途變異分析
    • 生物技術和製藥公司
    • 學術機構和政府研究機構
    • 委託研究組織 (Cros)

第 7 章市場分類：按產品、應用和最終用途分類的區域估計和趨勢分析

  • 區域市場概況
  • SWOT 分析，按因素（政治和法律、經濟和技術）
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 2021-2030 年市場規模、預測、趨勢分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
  • 亞太地區
    • 日本
    • 中國
    • 韓國
    • 印度
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • 中東和非洲 (MEA)
    • 南非
    • 沙特阿拉伯

第 8 章競爭格局

  • 頂級 CRISPR 創新者及其研究重點
  • 戰略框架
  • 市場進入者分類
  • 公司簡介
    • CARIBOU BIOSCIENCES
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • ASTRAZENECA
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • INTELLIA THERAPEUTICS, INC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • ADDGENE
      • 公司簡介
      • 財務業績
      • 產品基準
    • CRISPR THERAPEUTICS
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • NEW ENGLAND BIOLABS
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Thermo Fisher Scientific, Inc.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • SYNTHEGO
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • MAMMOTH BIOSCIENCES
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • INSCRIPTA, INC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • CIBUS
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • BEAM THERAPEUTICS
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • PLANTEDIT
      • 公司簡介
      • 產品基準
    • VERTEX PHARMACEUTICALS INCORPORATED
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • GENSCRIPT
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • INTEGRATED DNA TECHNOLOGIES
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • LONZA
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • MERCK
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • HERA BIOLABS
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • ORIGENE TECHNOLOGIES, INC.
      • 公司簡介
      • 財務業績
      • 產品基準
    • RECOMBINETICS, INC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
Product Code: GVR-1-68038-375-1

CRISPR And Cas Genes Market Growth & Trends:

The global CRISPR and Cas genes market size is expected to reach USD 9.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 17.9% during the forecast period, owing to the increasing usage of CRISPR and Cas genes systems in the biomedical research field. The use of CRISPR-Cas systems in diagnostics and the assessment of evolutionary analysis in prokaryotes has significantly increased, owing to the developments in the field of genome editing. The application of this technology enables easy and cost-efficient editing of genes. Genome editing has made a significant advancement in biomedical research, with the present trend of cutting-edge techniques paving the way for the future treatment of different genetic and non-genetic disorders.

The development and implementation of more effective ways for gene targeting and the generation of gene-edited avian species have been facilitated by the availability of the CRISPR/Cas9-mediated gene and genome editing technology. According to an article published on Frontiers in February 2021, CRISPR/Cas9 has become a robust and important tool for gene editing in the poultry industry. Potential applications in several fields would further boost the demand for this technology. The COVID-19 outbreak shifted the researcher's emphasis to the development of COVID-19 molecular diagnostic tools based on this technology. For instance, in March 2021, Nanyang Technological University researchers in Singapore created a COVID-19 test based on CRISPR that provides results in 30 minutes.

Even after the virus has mutated, this test still discovers it. This would further encourage the other key players to leverage this technique, thereby driving the industry's growth. This technology is increasingly being used for several medical and other applications. Competition over patents for such a gene-editing technology is expected to grow, as more academic institutions and biotech companies attempt to develop new commercial applications of this technology. In addition, there is a lot of potential for this technique to advance with the use of machine learning technologies. For instance, in August 2022, Synthego launched engineered cell libraries, a cutting-edge service that expands access to CRISPR by giving arrayed CRISPR-edited cells for use directly in functional screening experiments.

It has potential applications in disease research. Key players offer tools and solutions for each step of the gene editing workflow. Integrating several tools, services, and improved processes makes it possible to complete research experiments rapidly and with little effort. Moreover, key players have raised significant funding to support the R&D of the CRISPR & Cas9 gene-editing approach. For instance, in April 2021, Vertex Pharmaceuticals collaborated with CRISPR Therapeutics to develop and manufacture a new CRISPR/Cas9-based gene editing therapy called CTX001, a potential therapeutic option for transfusion-dependent beta-thalassemia and Sickle Cell Disease (SCD). In January 2020, Mammoth Biosciences raised USD 45 million to develop next-gen CRISPR products for therapeutics & diagnostics purposes. This would further be used to develop the company's CRISPR genes-driven diagnostics portfolio.

CRISPR And Cas Genes Market Report Highlights:

  • By product and services, the product segment dominated the industry in 2021 due to the availability of a broad range of product portfolios & rising adoption by various end-users
  • The biomedical segment dominated the industry in 2021. Extensive research and a significant rise in the number of research studies utilizing the advanced technique for genome editing have contributed to the segment growth
  • The biotechnology & pharmaceutical companies end-use segment captured the major revenue share in 2021. Key players are adopting this technology to produce biological models for human diseases and further accelerate new therapeutic target identification
  • North America captured the highest revenue share in 2021 owing to the presence of several pharmaceutical giants, increased research funding, a high number of research approvals, and the need for novel therapeutics

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Regional Scope
    • 1.1.2 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 Market Share Calculations
  • 1.9 List Of Secondary Sources
  • 1.10 List Of Abbreviations
  • 1.11 Objectives
    • 1.11.1 Objective 1
    • 1.11.2 Objective 2
    • 1.11.3 Objective 3
    • 1.11.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Crispr & Cas Genes Market Variables, Trends And Scope

  • 3.1 Market Segmentation & Scope
  • 3.2 Market Driver Analysis
    • 3.2.1 Growing Need For Novel Therapeutics
    • 3.2.2 Rising Demand For Gene Editing
    • 3.3.3 Rising Incidence Of Cancer
  • 3.3 Market Restraint Analysis
    • 3.3.1 Off-Target Effects Of Crispr Technology
    • 3.3.2 High-Cost Factor, Intellectual Property Disputes & Ethical Dilemma
  • 3.4 Crispr & Cas Genes Market-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.5 Industry Analysis - Porter's

Chapter 4 Product & Service Business Analysis

  • 4.1 Crispr And Cas Genes Market: Product & Service Movement Analysis
    • 4.1.1 By Product
      • 4.1.1.1 Global Crispr And Cas Genes Products Market, 2018 - 2030 (USD Million)
      • 4.1.1.2 Kits & Enzymes
      • 4.1.1.2.1 Global Crispr And Cas Genes Kits And Enzymes Market, 2018 - 2030 (USD Million)
      • 4.1.1.2.2 Vector-Based Cas9
      • 4.1.1.2.2.1 Global Vector-Based Crispr And Cas Genes Market, 2018 - 2030 (USD Million)
      • 4.1.1.2.3 Dna-Free Cas9
      • 4.1.1.2.3.1 Global Dna-Free Crispr And Cas Genes Market, 2018 - 2030 (USD Million)
      • 4.1.1.3 Libraries
      • 4.1.1.3.1 Global Crispr And Cas Genes Libraries Market, 2018 - 2030 (USD Million)
      • 4.1.1.4 Design Tools
      • 4.1.1.4.1 Global Crispr And Cas Genes Design Tool Market, 2018 - 2030 (USD Million)
      • 4.1.1.5 Antibodies
      • 4.1.1.5.1 Global Crispr And Cas Genes Antibodies Market, 2018 - 2030 (USD Million)
      • 4.1.1.6 Others
      • 4.1.1.6.1 Global Crispr And Cas Genes Market For Others, 2018 - 2030 (USD Million)
    • 4.1.2 By Service
      • 4.1.2.1 Global Crispr And Cas Genes Service Market, 2018 - 2030 (USD Million)
      • 4.1.2.2 Cell Line Engineering
      • 4.1.2.2.1 Global Cell Engineering Services Market, 2018 - 2030 (USD Million)
      • 4.1.2.3 gRNA Design
      • 4.1.2.3.1 Global gRNA Design Market, 2018 - 2030 (USD Million)
      • 4.1.2.4 Microbial Gene Editing
      • 4.1.2.4.1 Global Microbial Gene Editing Market, 2018 - 2030 (USD Million)
      • 4.1.2.5 Dna Synthesis
      • 4.1.2.5.1 Global Dna Synthesis Market, 2018 - 2030 (USD Million)

Chapter 5 Application Business Analysis

  • 5.1 Crispr And Cas Genes Market: Application Movement Analysis
    • 5.1.1 Biomedical
      • 5.1.1.1 Global Crispr And Cas Genes Market For Biomedical, 2018 - 2030 (USD Million)
      • 5.1.1.2 Genome Engineering
      • 5.1.1.2.1 Global Crispr And Cas Genes Market For Genome Engineering, 2018 - 2030 (USD Million)
      • 5.1.1.3 Disease Model Studies
      • 5.1.1.3.1 Global Crispr And Cas Genes Market For Disease Model Studies, 2018 - 2030 (USD Million)
      • 5.1.1.4 Functional Genomics
      • 5.1.1.4.1 Global Crispr And Cas Genes Market For Functional Genomics, 2018 - 2030 (USD Million)
      • 5.1.1.5 Epigenetics
      • 5.1.1.5.1 Global Crispr And Cas Genes Market For Epigenetics, 2018 - 2030 (USD Million)
      • 5.1.1.6 Others
      • 5.1.1.6.1 Global Crispr And Cas Genes Market For Others, 2018 - 2030 (USD Million)
    • 5.1.2 Agriculture
      • 5.1.2.1 Global Crispr And Cas Genes Market For Agriculture, 2018 - 2030 (USD Million)

Chapter 6 End-Use Business Analysis

  • 6.1 Crispr And Cas Genes Market: End-Use Movement Analysis
    • 6.1.1 Biotechnology & Pharmaceutical Companies
      • 6.1.1.1 Global Crispr And Cas Genes Market For Biotechnology & Pharmaceutical Companies, 2018 - 2030 (USD Million)
    • 6.1.2 Academics & Government Research Institutes
      • 6.1.2.1 Global Crispr And Cas Genes Market For Academics & Government Research Institutes, 2018 - 2030 (USD Million)
    • 6.1.3 Contract Research Organizations (Cros)
      • 6.1.3.1 Global Crispr And Cas Genes Market For Contract Research Organizations (Cros), 2018 - 2030 (USD Million)

Chapter 7 Market Categorization: Regional Estimates & Trend Analysis by Product, Application & End-use

  • 7.1 Regional Market Snapshot
  • 7.2 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
    • 7.2.1 North America
    • 7.2.2 Europe
    • 7.2.3 Asia Pacific
    • 7.2.4 Latin America
    • 7.2.5 Middle East And Africa
  • 7.3 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
  • 7.4 North America
    • 7.4.1 North America CRISPR And Cas Genes Market Estimates And Forecast, 2018-2030, (USD Billion)
    • 7.4.2 U.S.
      • 7.4.2.1 U.S. CRISPR & Cas Gene Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.4.3 Canada
      • 7.4.3.1 Canada CRISPR & Cas Genes Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 7.5 Europe
    • 7.5.1 Europe CRISPR And Cas Genes Market Estimates And Forecast, 2018-2030, (USD Billion)
    • 7.5.2 Germany
      • 7.5.2.1 Germany CRISPR & Cas Gene Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.3 U.K.
      • 7.5.3.1 U.K. CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.5.4 France
      • 7.5.4.1 France CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.5.5 Italy
      • 7.5.5.1 Italy CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.5.6 Spain
      • 7.5.6.1 Spain CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.6 Asia Pacific
    • 7.6.1 Asia Pacific CRISPR And Cas Genes Market Estimates And Forecast, 2018-2030, (USD Billion)
    • 7.6.2 Japan
      • 7.6.2.1 Japan CRISPR & Cas Genes Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.3 China
      • 7.6.3.1 China CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.6.4 South Korea
      • 7.6.4.1 South Korea CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.6.5 India
      • 7.6.5.1 India CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.7 Latin America
    • 7.7.1 Latin America CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.7.2 Brazil
      • 7.7.2.1 Brazil CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.7.3 Mexico
      • 7.7.3.1 Mexico CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.8 Middle East & Africa (Mea)
    • 7.8.1 MEA CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.8.2 South Africa
      • 7.8.2.1 South Africa CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.8.3 Saudi Arabia
      • 7.8.3.1 Saudi Arabia CRISPR And Cas Genes Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Top CRISPR Innovators and Their Research Focus
  • 8.2 Strategy Framework
  • 8.3 Market Participant Categorization
  • 8.4 Company Profiles
    • 8.4.1 CARIBOU BIOSCIENCES
      • 8.4.1.1 Company Overview
      • 8.4.1.2 Financial Performance
      • 8.4.1.3 Product Benchmarking
      • 8.4.1.4 Strategic Initiatives
    • 8.4.2 ASTRAZENECA
      • 8.4.2.1 Company Overview
      • 8.4.2.2 Financial Performance
      • 8.4.2.3 Product Benchmarking
      • 8.4.2.4 Strategic Initiatives
    • 8.4.3 INTELLIA THERAPEUTICS, INC.
      • 8.4.3.1 Company Overview
      • 8.4.3.2 Financial Performance
      • 8.4.3.3 Product Benchmarking
      • 8.4.3.4 Strategic Initiatives
    • 8.4.4 ADDGENE
      • 8.4.4.1 Company Overview
      • 8.4.4.2 Financial Performance
      • 8.4.4.3 Product Benchmarking
    • 8.4.5 CRISPR THERAPEUTICS
      • 8.4.5.1 Company Overview
      • 8.4.5.2 Financial Performance
      • 8.4.5.3 Product Benchmarking
      • 8.4.5.4 Strategic Initiatives
    • 8.4.6 NEW ENGLAND BIOLABS
      • 8.4.6.1 Company Overview
      • 8.4.6.2 Financial Performance
      • 8.4.6.3 Product Benchmarking
      • 8.4.6.4 Strategic Initiatives
    • 8.4.7 THERMO FISHER SCIENTIFIC, INC.
      • 8.4.7.1 Company Overview
      • 8.4.7.2 Financial Performance
      • 8.4.7.3 Product Benchmarking
      • 8.4.7.4 Strategic Initiatives
    • 8.4.8 SYNTHEGO
      • 8.4.8.1 Company Overview
      • 8.4.8.2 Financial Performance
      • 8.4.8.3 Product Benchmarking
      • 8.4.8.4 Strategic Initiatives
    • 8.4.9 MAMMOTH BIOSCIENCES
      • 8.4.9.1 Company Overview
      • 8.4.9.2 Financial Performance
      • 8.4.9.3 Product Benchmarking
      • 8.4.9.4 Strategic Initiatives
    • 8.4.10 INSCRIPTA, INC.
      • 8.4.10.1 Company Overview
      • 8.4.10.2 Financial Performance
      • 8.4.10.3 Product Benchmarking
      • 8.4.10.4 Strategic Initiatives
    • 8.4.11 CIBUS
      • 8.4.11.1 Company Overview
      • 8.4.11.2 Financial Performance
      • 8.4.11.3 Product Benchmarking
      • 8.4.11.4 Strategic Initiatives
    • 8.4.12 BEAM THERAPEUTICS
      • 8.4.12.1 Company Overview
      • 8.4.12.2 Financial Performance
      • 8.4.12.3 Product Benchmarking
      • 8.4.12.4 Strategic Initiatives
    • 8.4.13 PLANTEDIT
      • 8.4.13.1 Company Overview
      • 8.4.13.2 Product Benchmarking
    • 8.4.14 VERTEX PHARMACEUTICALS INCORPORATED
      • 8.4.14.1 Company Overview
      • 8.4.14.2 Financial Performance
      • 8.4.14.3 Product Benchmarking
      • 8.4.14.4 Strategic Initiatives
    • 8.4.15 GENSCRIPT
      • 8.4.15.1 Company Overview
      • 8.4.15.2 Financial Performance
      • 8.4.15.3 Product Benchmarking
      • 8.4.15.4 Strategic Initiatives
    • 8.4.16 INTEGRATED DNA TECHNOLOGIES
      • 8.4.16.1 Company Overview
      • 8.4.16.2 Financial Performance
      • 8.4.16.3 Product Benchmarking
      • 8.4.16.4 Strategic Initiatives
    • 8.4.17 LONZA
      • 8.4.17.1 Company Overview
      • 8.4.17.2 Financial Performance
      • 8.4.17.3 Product Benchmarking
      • 8.4.17.4 Strategic Initiatives
    • 8.4.18 MERCK
      • 8.4.18.1 Company Overview
      • 8.4.18.2 Financial Performance
      • 8.4.18.3 Product Benchmarking
      • 8.4.18.4 Strategic Initiatives
    • 8.4.19 HERA BIOLABS
      • 8.4.19.1 Company Overview
      • 8.4.19.2 Product Benchmarking
      • 8.4.19.3 Strategic Initiatives
    • 8.4.20 ORIGENE TECHNOLOGIES, INC.
      • 8.4.20.1 Company Overview
      • 8.4.20.2 Financial Performance
      • 8.4.20.3 Product Benchmarking
    • 8.4.21 RECOMBINETICS, INC.
      • 8.4.21.1 Company Overview
      • 8.4.21.2 Financial Performance
      • 8.4.21.3 Product Benchmarking
      • 8.4.21.4 Strategic Initiative

List of Tables

  • Table 1 List of Tables
  • Table 2 List of Secondary Sources
  • Table 3 List of Abbreviations
  • Table 4 Global CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 5 Global CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 7 Global CRISPR and Cas Genes Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America CRISPR and Cas Genes Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 10 North America CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 North America CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 12 U.S. CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 13 U.S. CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 14 U.S. CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 15 Canada CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 16 Canada CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 17 Canada CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 18 Europe CRISPR and Cas Genes Market, by Country, 2018 - 2030 (USD Million)
  • Table 19 Europe CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 20 Europe CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 21 Europe CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 22 Germany CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 23 Germany CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 Germany CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 25 U.K. CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 26 U.K. CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 27 U.K. CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 28 France CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 29 France CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 30 France CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 31 Italy CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 32 Italy CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 Italy CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 34 Spain CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 35 Spain CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 36 Spain CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific CRISPR and Cas Genes Market, by Country, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 41 China CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 42 China CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 43 China CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 44 Japan CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 45 Japan CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 46 Japan CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 47 India CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 48 India CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 India CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 50 South Korea CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 51 South Korea CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 South Korea CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 53 Latin America CRISPR and Cas Genes Market, by Country, 2018 - 2030 (USD Million)
  • Table 54 Latin America CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 55 Latin America CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 56 Latin America CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 57 Brazil CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 58 Brazil CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 59 Brazil CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 60 Mexico CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 61 Mexico CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 62 Mexico CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 63 Argentina CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 64 Argentina CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Argentina CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 66 Middle East and Africa CRISPR and Cas Genes Market, by Country, 2018 - 2030 (USD Million)
  • Table 67 Middle East and Africa CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 68 Middle East and Africa CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 69 Middle East and Africa CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 70 South Africa CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 71 South Africa CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 72 South Africa CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)
  • Table 73 Saudi Arabia CRISPR and Cas Genes Market, by Product and Service, 2018 - 2030 (USD Million)
  • Table 74 Saudi Arabia CRISPR and Cas Genes Market, by Application, 2018 - 2030 (USD Million)
  • Table 75 Saudi Arabia CRISPR and Cas Genes Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 CRISPR and Cas genes, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 14 Regional Marketplace: Key Takeaways
  • Fig. 15 Global CRISPR and Cas genes Market, for Product, 2018 - 2030 (USD Million)
  • Fig. 16 Global CRISPR and Cas genes Market, for Kits & Enzymes, 2018 - 2030 (USD Million)
  • Fig. 17 Global CRISPR and Cas genes Market, for Vector-based Cas9 2018 - 2030 (USD Million)
  • Fig. 18 Global CRISPR and Cas genes Market, for DNA-free Cas9 2018 - 2030 (USD Million)
  • Fig. 19 Global CRISPR and Cas genes Market, for Libraries, 2018 - 2030 (USD Million)
  • Fig. 20 Global CRISPR and Cas genes Market, for Design Tool, 2018 - 2030 (USD Million)
  • Fig. 21 Global CRISPR and Cas genes Market, for Antibodies , 2018 - 2030 (USD Million)
  • Fig. 22 Global CRISPR and Cas genes Market, for Others , 2018 - 2030 (USD Million)
  • Fig. 23 Global CRISPR and Cas genes Market, for Service, 2018 - 2030 (USD Million)
  • Fig. 24 Global CRISPR and Cas genes Market, for Cell Line Engineering , 2018 - 2030 (USD Million)
  • Fig. 25 Global CRISPR and Cas genes Market, for gRNA Design , 2018 - 2030 (USD Million)
  • Fig. 26 Global CRISPR and Cas genes Market, for Microbial Gene Editing , 2018 - 2030 (USD Million)
  • Fig. 27 Global CRISPR and Cas genes Market, for DNA synthesis , 2018 - 2030 (USD Million)
  • Fig. 28 Global CRISPR and Cas genes Market, for Biomedical , 2018 - 2030 (USD Million)
  • Fig. 29 Global CRISPR and Cas genes Market, for Genome Engineering, 2018 - 2030 (USD Million)
  • Fig. 30 Global CRISPR and Cas genes Market, for Disease Model Studies, 2018 - 2030 (USD Million)
  • Fig. 31 Global CRISPR and Cas genes Market, for Functional Genomics , 2018 - 2030 (USD Million)
  • Fig. 32 Global CRISPR and Cas genes Market, for Epigenetics, 2018 - 2030 (USD Million)
  • Fig. 33 Global CRISPR and Cas genes Market, for Others , 2018 - 2030 (USD Million)
  • Fig. 34 Global CRISPR and Cas genes Market, for Agricultural , 2018 - 2030 (USD Million)
  • Fig. 35 Global CRISPR and Cas genes Market, for Biotechnology & Pharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 36 Global CRISPR and Cas genes Market, for Academics & Government Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 37 Global CRISPR and Cas genes Market, for Contract Research Organizations (CROs), 2018 - 2030 (USD Million)
  • Fig. 38 Regional Outlook, 2021 & 2030
  • Fig. 39 North America CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 42 Europe CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 44 U.K. CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 45 France CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 46 Italy CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 47 Spain CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 50 China CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 51 India CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa CRISPR and Cas genes Market, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia CRISPR and Cas genes Market, 2018 - 2030 (USD Million)